Risk for heterosexual HIV transmission among non-injecting female partners of injection drug users in Estonia

AIDS and Behavior

Volumn 17, Issue 3, 2013, Pages 879-888

  Uuskula A ^a   McMahon, J M ^b   Kals, M ^a   Talu, A ^c   Abel Ollo, K ^c   Ruutel K ^c   Des Jarlais, D C ^d  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF ROCHESTER   (United States)

^c NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Estonia; HIV incidence; Injecting drug users; Main sexual partners

Indexed keywords

ADULT; ARTICLE; DISEASE TRANSMISSION; ESTONIA; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERVIEW; MALE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; SUBSTANCE ABUSE;

ADULT; ESTONIA; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; MALE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84880801177     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0078-9     Document Type: Article

References (51)

1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2008. Stockholm: European Centre for Disease Prevention and Control; 2009.
2. UNAIDS. AIDS info database (http://www.aidsinfoonline.org/). Accessed 01 July 2011.
3. Uusküla A, Rajaleid K, Talu A, Abel K, Rüütel K, Hay G. Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addict Res Theory. 2007;15(4):411-24.
4. Platt L, Bobrova N, Rhodes T, Uusküla A, Parry JV, Rüütel K, Talu A, Abel K, Rajaleid K, Judd A. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS. 2006;20(16):2120-3. (Pubitemid 44611068)
5. Uusküla A, Kals M, Rajaleid K, Abel K, Talu A, Rüütel K, Platt L, Rhodes T, Dehovitz J, Jarlais DD. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf). 2008;30(2):119-25.
6. Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Jarlais DCD. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduct J. 2009;6:3.
7. European Centre for the Epidemiological Monitoring of HIV and AIDS, 2002. HIV/AIDS Surveillance in Europe End-year report 2002. Saint-Maurice: Institut de Veille Sanitaire. 2002;68:22.
8. European Centre for the Epidemiological Monitoring of HIV and AIDS, 2006. HIV/AIDS Surveillance in Europe End-year report 2006. Saint-Maurice: Institut de Veille Sanitaire. 2006;75:12.
9. Health board Estonia. HIV/AIDS statistics 2009. http://www.terviseamet. ee/nakkushaigused/nakkushaigustesse-haigestumine/hiv-ja-aids.html. Accessed 24 May 2011.
10. Laisaar KT, Avi R, Dehovitz J, Uusküla A. Estonia at the threshold of the fourth decade of the AIDS era in Europe. AIDS Res Hum Retroviruses. 2011;27(8):841-51.
11. Abdala N, Krasnoselskikh TV, Durante AJ, Timofeeva MY, Verevochkin SV, Kozlov AP. Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia. Eur Addict Res. 2008;14(1):19-25.
12. Uusküla A, McNutt LA, Dehovitz J, et al. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD AIDS. 2007;18(1):41-6.
13. Niccolai LM, Shcherbakova IS, Toussova OV, Kozlov AP, Heimer R. The potential for bridging of HIV transmission in the Russian federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health. 2009;86(1):131-43.
14. Toussova O, Shcherbakova I, Volkova G, Niccolai L, Heimer R, Kozlov A. Potential bridges of heterosexual HIV transmission from drug users to the general population in St. Petersburg, Russia: is it easy to be a young female? J Urban Health. 2009;86(1):121-30.
15. Health board Estonia. HIV/AIDS statistics 2007. http://www.terviseamet. ee/fileadmin/dok/Nakkushaigused/HIV/hivstatistika-2007.pdf. Accessed 24 May 2011.
16. McMahon JM, Tortu S, Torres L, Pouget ER, Hamid R. Recruitment of heterosexual couples in public health research: a study protocol. BMC Med Res Methodol. 2003;3:24.
17. Witte SS, El-Bassel N, Gilbert L, Wu E, Chang M, Steinglass P. Recruitment of minority women and their main sexual partners in an HIV/STI prevention trial. J Womens Health. 2004;13(10):1137-47.
18. Jarlais DCD, Perlis TE, Stimson GV, Poznyak V. WHO Phase II drug injection collaborative study group. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II. BMC Public Health. 2006;6:54. (Pubitemid 43786792)
19. Pinkerton SD, Abramson PR. Evaluating the risks: a Bernoulli process model of HIV infection and risk reduction. Eval Rev. 1993;17:504-28.
20. Pinkerton SD, Abramson PR. The Bernoulli-process model of HIV transmission: applications and implications. In: Holtgrave DR, editor. Handbook of economic evaluation of HIV prevention programs. New York: Plenum press; 1998. p. 13-32.
21. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009;9(2):118-29.
22. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39(4):1048-63.
23. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403. (Pubitemid 40563350)
24. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis. 2008;198(5):687-93.
25. Pinkerton S. Probability of HIV transmission during acute infection in Rakai, Uganda. AIDS Behav. 2008;12:677-84.
26. Leynaert B, Downs AM, de Vincenzi I. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European study group on heterosexual transmission of HIV. Am J Epidemiol. 1998;148:88-96. (Pubitemid 28317549)
27. Pinkerton SD, Abramson PR, Kalichman SC, Catz SL, Johnson-Masotti AP. Secondary HIV transmission rates in a mixed-gender sample. Int J STD AIDS. 2000;11(1):38-44. (Pubitemid 30055135)
28. Watkins KE, Metzger D, Woody G, McLellan AT. Determinants of condom use among intravenous drug users. AIDS. 1993;7(5):719-23. (Pubitemid 23204967)
29. Lansky A, Thomas JC, Earp JA. Partner-specific sexual behaviors among persons with both main and other partners. Fam Plann Perspect. 1998;30(2):93-6. (Pubitemid 28216342)
30. Prevalence of HIV and other infections and risk behaviour among injecting drug users in Latvia, Lithuania and Estonia in 2007. Study report. National Institute for Health Development 2009:25. http://rahvatervis.ut.ee/bitstream/1/ 1826/1/TerviseArenguInstituut2009.pdf. Accessed 24 May 2011.
31. Pinkerton SD. How many sexually-acquired HIV-1 infections in the USA are due to acute-phase HIV-1 transmission? AIDS. 2007;21:1625-9. (Pubitemid 47075484)
32. Miller WC, Rosenberg NE, Rutstein SE, Powers KA. Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5(4):277-82.
33. Kapina M, Reid RCK, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH. HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trial. Sex Transm Dis. 2009;36(3):129-33.
34. Kumwenda NI, Kelly C, Hoffman I, Chirenje M, Coletti A, Ristow A, Martinson F, Brown J, Richardson B, Chilongozi D, Padian N, Taha T. HIV incidence among women of reproductive age in Malawi and Zimbabwe (HIVNET/HPTN 016A). International Conference on AIDS (15th: 2004: Bangkok, Thailand). Int Conf AIDS. 2004 Jul 11-16; 15: abstract no. ThOrC1426.
35. Rehle TM, Hallett TB, Shisana O, Pillay-vanWyk V, Zuma K, Carrara H, Jooste S. A decline in new HIV infections in south africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5(6):e11094.
36. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977-87.
37. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D. CAPRISA 004 trial group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-74.
38. Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002;166(7):894-9. (Pubitemid 34275509)
39. Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003;168(1):19-24. (Pubitemid 36241176)
40. Bruneau J, Zang G, al-Nachawati H, Daniel M, Lamothe F, Vincelette J. HIV incidence among injection drug users (IDU) in Montreal: the St Luc cohort 1992-2004. Can J Infect Dis Med Microbiol (CAHR Abstracts). 2006; 17 Supplement A. http://www.cahr-acrv.ca/english/resources/abstracts-2006/abs/328.htm. Accessed 22 January 2010.
41. Navarro IH, Alastrue I, Del Amo J, Santos C, Ferreros I, Tasa T, Pérez-Hoyos S. Differences between women and men in serial HIV prevalence and incidence trends. Eur J Epidemiol. 2008;23(6):435-40.
42. Meader N, Li R, Jarlais DCD, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev. 2010;1:CD007192.
43. Semaan S, Jarlais DCD, Sogolow E, Johnson WD, Hedges LV, Ramirez G, Flores SA, Norman L, Sweat MD, Needle R. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002;30(1):S73-93.
44. Harvey SM, Bird ST, Galavotti C, Duncan EA, Greenberg D. Relationship power, sexual decision-making and condom use among women at risk for HIV/STDs. Women Health. 2002;36(4):69-84. (Pubitemid 36175605)
45. El-Bassel N, Jemmott JB, Landis JR, Pequegnat W, Wingood GM, Wyatt GE, Bellamy SL. For the NIMH multisite HIV/STD prevention trial for African American couples group. National Institute of Mental Health Multisite Eban HIV/STD prevention intervention for African American HIV Serodiscordant couples: a cluster randomized trial. Arch Intern Med. 2010;170(17):1594-601.
46. Jarlais DCD, Bramson H, Wong C, Gostnell K, Hagan H, Arasteh K. Meta analysis of the international literature on racial/ethnic disparities in HIV infection among IDUs: First results. Paper presented at the XVIII International AIDS Conference, 2010, Vienna, Austria; Abstract number: TUPDD103.
47. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP. 2007 Reference group to the UN on HIV and injecting drug use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733-45.
48. Platt L, Hickman M, Rhodes T, Mikhailova L, Karavashkin V, Vlasov A, Tilling K, Hope V, Khutorksoy M, Renton A. The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage. Addiction. 2004;99(11):1430-8. (Pubitemid 39490530)
49. Lowndes C, Renton A, Alary M, Grassly G, Garnett, Stimson G. Conditions for widespread heterosexual spread of HIV in the Russian federation: implications for research, monitoring and prevention. Int J Drug Policy. 2003;14:45-62. (Pubitemid 36332163)
50. Archibald CP, Reid DC, Choudhri Y. Cule SM: HIV among injecting drug users and spread to the general population: putting the cart before the horse. Int J Drug Policy. 2003;14:75-8. (Pubitemid 36332165)
51. Blanchard JF. Populations, pathogens, and epidemic phases: closing the gap between theory and practice in the prevention of sexually transmitted diseases. Sex Transm Infect. 2002;78(Suppl 1):i183-8.